Faraz Kazmi

1.1k total citations
17 papers, 591 citations indexed

About

Faraz Kazmi is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Faraz Kazmi has authored 17 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Faraz Kazmi's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Biochemical and Molecular Research (4 papers). Faraz Kazmi is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers) and Biochemical and Molecular Research (4 papers). Faraz Kazmi collaborates with scholars based in United States, Belgium and Italy. Faraz Kazmi's co-authors include Andrew Parkinson, David B. Buckley, Phyllis Yerino, Brian W. Ogilvie, Brandy L. Paris, Chad Pope, Ryan S. Funk, Paul Toren, Amin Rostami‐Hodjegan and L. Haupt and has published in prestigious journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Faraz Kazmi

17 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faraz Kazmi United States 10 246 194 156 81 56 17 591
Paul Toren United States 11 284 1.2× 206 1.1× 193 1.2× 96 1.2× 86 1.5× 22 661
Rowan Stringer Switzerland 17 267 1.1× 232 1.2× 216 1.4× 45 0.6× 56 1.0× 23 874
Yasushi Yoshigae Japan 14 165 0.7× 144 0.7× 164 1.1× 96 1.2× 81 1.4× 27 568
Hiroshi Komura Japan 17 286 1.2× 245 1.3× 273 1.8× 82 1.0× 68 1.2× 40 817
Haruo Iwabuchi Japan 14 222 0.9× 260 1.3× 167 1.1× 54 0.7× 27 0.5× 34 578
Xavier Boulenc France 15 336 1.4× 198 1.0× 303 1.9× 78 1.0× 94 1.7× 19 814
Jackie C. Bloomer United Kingdom 13 268 1.1× 261 1.3× 180 1.2× 50 0.6× 50 0.9× 20 751
Hilde Bohets Belgium 11 311 1.3× 209 1.1× 254 1.6× 68 0.8× 72 1.3× 18 769
Nancy Hakooz Jordan 15 318 1.3× 150 0.8× 200 1.3× 63 0.8× 82 1.5× 44 595
Gemma L. Dickinson United States 12 254 1.0× 244 1.3× 246 1.6× 102 1.3× 122 2.2× 25 817

Countries citing papers authored by Faraz Kazmi

Since Specialization
Citations

This map shows the geographic impact of Faraz Kazmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faraz Kazmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faraz Kazmi more than expected).

Fields of papers citing papers by Faraz Kazmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faraz Kazmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faraz Kazmi. The network helps show where Faraz Kazmi may publish in the future.

Co-authorship network of co-authors of Faraz Kazmi

This figure shows the co-authorship network connecting the top 25 collaborators of Faraz Kazmi. A scholar is included among the top collaborators of Faraz Kazmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faraz Kazmi. Faraz Kazmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Pietsch, E. Christine, Justin S. Cisar, Edgar Jacoby, et al.. (2024). Discovery of Alternative Binding Poses through Fragment-Based Identification of DHODH Inhibitors. ACS Medicinal Chemistry Letters. 15(3). 381–387. 1 indexed citations
2.
Zhang, Zhuming, Justin S. Cisar, Xiaochun Zhang, et al.. (2024). Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML. Journal of Medicinal Chemistry. 67(13). 11254–11272. 2 indexed citations
3.
Cisar, Justin S., Edgar Jacoby, Faraz Kazmi, et al.. (2022). N-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia. Journal of Medicinal Chemistry. 65(16). 11241–11256. 12 indexed citations
4.
Pietsch, E. Christine, P.L. Shaffer, Edgar Jacoby, et al.. (2020). A carboxylic acid isostere screen of the DHODH inhibitor Brequinar. Bioorganic & Medicinal Chemistry Letters. 30(22). 127589–127589. 7 indexed citations
5.
6.
7.
Haupt, L., Faraz Kazmi, Brian W. Ogilvie, et al.. (2015). The Reliability of Estimating Ki Values for Direct, Reversible Inhibition of Cytochrome P450 Enzymes from Corresponding IC50 Values: A Retrospective Analysis of 343 Experiments. Drug Metabolism and Disposition. 43(11). 1744–1750. 50 indexed citations
8.
9.
10.
11.
Czerwiński, Maciej, Faraz Kazmi, Andrew Parkinson, & David B. Buckley. (2014). Anti-CD28 Monoclonal Antibody–Stimulated Cytokines Released from Blood Suppress CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes In Vitro. Drug Metabolism and Disposition. 43(1). 42–52. 6 indexed citations
12.
13.
Kazmi, Faraz, et al.. (2013). Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells). Drug Metabolism and Disposition. 41(4). 897–905. 188 indexed citations
14.
Kazmi, Faraz, et al.. (2012). High-Resolution Mass Spectrometry Elucidates Metabonate (False Metabolite) Formation from Alkylamine Drugs during In Vitro Metabolite Profiling. Drug Metabolism and Disposition. 40(10). 1966–1975. 9 indexed citations
15.
Ogilvie, Brian W., Phyllis Yerino, Faraz Kazmi, et al.. (2011). The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel. Drug Metabolism and Disposition. 39(11). 2020–2033. 79 indexed citations
16.
Parkinson, Andrew, Faraz Kazmi, David B. Buckley, et al.. (2011). An Evaluation of the Dilution Method for Identifying Metabolism-Dependent Inhibitors of Cytochrome P450 Enzymes. Drug Metabolism and Disposition. 39(8). 1370–1387. 58 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Toren Breakdown of academic impact, for papers by Rowan Stringer Breakdown of academic impact, for papers by Yasushi Yoshigae Breakdown of academic impact, for papers by Hiroshi Komura Breakdown of academic impact, for papers by Haruo Iwabuchi Breakdown of academic impact, for papers by Xavier Boulenc Breakdown of academic impact, for papers by Jackie C. Bloomer Breakdown of academic impact, for papers by Hilde Bohets Breakdown of academic impact, for papers by Nancy Hakooz Breakdown of academic impact, for papers by Gemma L. Dickinson
Rankless by CCL
2026